12/6
05:31 am
rlmd
Relmada Therapeutics, Inc. (NASDAQ: RLMD) was downgraded by analysts at Mizuho from a "strong-buy" rating to a "hold" rating.
Low
Report
Relmada Therapeutics, Inc. (NASDAQ: RLMD) was downgraded by analysts at Mizuho from a "strong-buy" rating to a "hold" rating.
12/6
05:31 am
rlmd
Relmada Therapeutics, Inc. (NASDAQ: RLMD) was downgraded by analysts at Mizuho from a "strong-buy" rating to a "hold" rating.
Low
Report
Relmada Therapeutics, Inc. (NASDAQ: RLMD) was downgraded by analysts at Mizuho from a "strong-buy" rating to a "hold" rating.
12/5
08:02 am
rlmd
Relmada Therapeutics, Inc. (NASDAQ: RLMD) had its "market perform" rating re-affirmed by analysts at Leerink Partners. They now have a $1.00 price target on the stock, down previously from $10.00.
High
Report
Relmada Therapeutics, Inc. (NASDAQ: RLMD) had its "market perform" rating re-affirmed by analysts at Leerink Partners. They now have a $1.00 price target on the stock, down previously from $10.00.
12/5
08:01 am
rlmd
Relmada Therapeutics, Inc. (NASDAQ: RLMD) had its "neutral" rating re-affirmed by analysts at Mizuho. They now have a $1.00 price target on the stock, down previously from $23.00.
High
Report
Relmada Therapeutics, Inc. (NASDAQ: RLMD) had its "neutral" rating re-affirmed by analysts at Mizuho. They now have a $1.00 price target on the stock, down previously from $23.00.
12/5
08:01 am
rlmd
Relmada Therapeutics, Inc. (NASDAQ: RLMD) had its "neutral" rating re-affirmed by analysts at Mizuho. They now have a $1.00 price target on the stock, down previously from $23.00.
High
Report
Relmada Therapeutics, Inc. (NASDAQ: RLMD) had its "neutral" rating re-affirmed by analysts at Mizuho. They now have a $1.00 price target on the stock, down previously from $23.00.
12/5
04:40 am
rlmd
Rating for RLMD
High
Report
Rating for RLMD
12/5
04:40 am
rlmd
Rating for RLMD
High
Report
Rating for RLMD
12/4
08:55 pm
rlmd
Relmada Therapeutics downgraded to Neutral from Outperform at Mizuho
High
Report
Relmada Therapeutics downgraded to Neutral from Outperform at Mizuho
12/4
08:55 pm
rlmd
Relmada Therapeutics downgraded to Neutral from Outperform at Mizuho
High
Report
Relmada Therapeutics downgraded to Neutral from Outperform at Mizuho